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Background
　In massive hemorrhage, coagulation dysfunction 
can occur because of consumption of the coagulation 
factors due to the bleeding and hemodilution of blood 
components by a large quantity of infusion.1), 2) Radical 
prostatectomy can lead to severe bleeding, and 
therefore patients undergoing this procedure often 
donate autologous whole blood prior to surgery. The 
main efect of preoperative autologous blood donation 
(PABD) is increasing red blood cels (RBC) to 
maintain circulating oxygen-carrying capacity. In fact, 
PABD has been evaluated as reducing the need for 
homologous blood transfusion.3)－7) Another benefit is 
including the components of coagulation system. 
Minatoguchi et al. have investigated coagulation 
factors in whole blood stored at 4°C for five weeks.8) 
In this study, especialy fibrinogen was maintained 
above the critical level through the stored period. 
However, there have been few studies of efects on 
patients’ coagulability of PABD.
Autologous transfusion in radical prostatectomy:
Assessment of coagulability by rotational thromboelastometry
Nozomi Yashima*, Tomofumi Watanabe*, Misato Kurota*, Airi Kumasaka*
Futaba Kurihara**, Kei Otaki*, Shinya Oda***, Kaneyuki Kawamae*
*Department of Anesthesiology Yamagata University faculty of Medicine
**Kahoku Hospital
***Sanyudo Hospital
（Accepted March 7, 2017）
Background: Radical prostatectomy can lead to severe bleeding. Therefore, patients undergoing this 
procedure often donate autologous whole blood prior to surgery. In this study, we aimed to evaluate the 
clinical eficacy of transfusing preserved autologous whole blood on coagulation activity as assessed by 
rotational thromboelastometry (ROTEM遺). 
Methods: This study included patients who underwent radical prostatectomy and donated 1200 mL of 
whole blood prior to surgery. Blood samples for ROTEM analyses were drawn at four points; after 
induction, prior to transfusion of autologous whole blood, at the end of surgery and the morning after 
surgery. Clotting time (CT), clot formation time (CFT) and maximal clot firmness (MCF) were measured 
using EXTEM tests; MCF was measured using FIBTEM tests.
Results: The average blood loss in 11 patients was 1635 ± 954 g. In EXTEM, CFT was significantly 
prolonged and MCF was significantly reduced prior to transfusion. These parameters were significantly 
improved by the next morning. In FIBTEM, there were no significant diferences among samples 
obtained after induction, prior to transfusion and at the end of surgery. In contrast, MCF was 
significantly improved the morning after surgery. 
Conclusion: ROTEM parameters were impaired during the procedure. Transfusion of autologous whole 
blood did not alter these parameters during the intraoperative period.
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Recently, rotational thromboelastometry (ROTEM遺) 
has been used as a point-of-care device to monitor 
coagulation activity in situations, which leads to 
severe bleeding such as cardiac surgery9), liver 
transplantation10) and trauma11). Conventional coagu-
lation tests including platelet counts, fibrinogen 
concentration, prothrombin time (PT), and activated 
partial thromboplastin time (aPTT) have some 
problems. These tests needed a long turn-around 
time, because the sample was transferred to the 
laboratory and centrifuged to separate plasma from 
whole blood. Furthermore, these results were 
indicated a part of coagulability due to using only the 
plasma. In contrast, ROTEM can be performed using 
the whole blood sample at the operation room, 
therefore, the judgement whether coagulation 
dysfunction occurs is earlier. Furthermore, these 
results were visualy displayed the graphic date in 
real-time and represented various parts of hemosta-
sis. Thereby early checkup and appropriate treatment 
are enabled in the operating room.
　In this study, we aimed to evaluate the 
coagulopathy caused by severe bleeding during 
surgery assessed by ROTEM遺, further, to evaluate the 
clinical eficacy of transfusing preserved autologous 
whole blood during surgery on coagulation activity 
assessed by ROTEM遺.
Materials and Methods
　This study included patients who underwent 
elective radical prostatectomy at Yamagata university 
hospital between September 2012 and January 2014. 
Al patients donated 1200 ml of whole blood within 
four weeks prior to surgery. Whole blood was colected 
into a 400-ml blood colection bag containing citrate 
phosphate dextrose adenine-1 (CPDA-1) liquid as 
anticoagulant and this procedure was performed 
three times until surgery. We excluded patients who 
had already had coagulopathy defined as at least one 
of folows; PT-INR was more than 1.20, aPTT was 
more than 35 seconds, or platelet count was less than 
10×104/mm3. We also excluded patients who had 
preoperatively dosed anticoagulants.
　Al patients had general anesthesia and epidural 
analgesia. Before induction, each patient was inserted 
epidural catheter first at the level of thoracic or 
lumber vertebra. Anesthesia protocol was not strictly 
defined, each anesthesiologist decided to conduct how 
to manage the general anesthesia by him/herself. 
Anesthesia was induced with thiopental or propofol 
and maintained with sevoflurane or propofol and 
remi-fentanyl. Rocuronium was administrated before 
intubation and used for muscle relaxation as 
appropriate. End-tracheal intubation was performed 
as an airway management. 
　Blood loss during surgery was calculated by the 
weight change of the absorbent gauzes and by the 
volume change in the suction reservoirs, although the 
latter was included urine after urethrectomy. 
　Blood samples for ROTEM遺 analyses were colected 
through arterial cannula into citrated plastic tubes, at 
a volume ratio of 1:10. Blood samples were drawn at 
four points; after induction as a baseline (T1), prior to 
transfusion of autologous whole blood (T2), at the end 
of surgery (T3) and the morning after surgery (T4) 
(Figure 1). These were immediately or at least within 
2 hours analyzed using ROTEM遺 delta (Amco Inc, 
Tokyo, Japan) as folows. The folowing ROTEM 
parameters were recorded: clotting time (CT, s), clot 
formation time (CFT, s) and maximal clot firmness 
(MCF, mm) using EXTEM test, and MCF using 
FIBTEM tests at each point in detail in Figure 2,  
3.2), 12) CT is defined time from start of measurement 
until initiation of clotting and means initial thrombin 
and fibrin formation. CFT is defined time from 
initiation of clotting until a clot firmness of 20 mm 
and means propagation of clot formation. MCF is the 
maximum amplitude and means the final clot 
firmness. The EXTEM test is performed by additional 
of rabbit brain tissue factor as extrinsic activator and 
Figure 1. The timing of blood sample for ROTEM遺 
analyses. Blood samples were drawn at four points; after 
induction as a baseline (T1), prior to transfusion of 
autologous whole blood (T2), at the end of surgery (T3) 
and the morning after surgery (T4).
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CaCl2. Therefore, CT and CFT on EXTEM represent 
extrinsic activators (normal value; CT 42-74 s, CFT 
46-148 mm) and MCF on EXTEM represents the 
complex activity between fibrinogen and platelet 
(normal value; MCF on EXTEM 49-71 mm). On the 
other hand, the FIBTEM test is performed by 
additional of CaCl2 and cytochalasin D as a potent 
platelet inhibitor, therefore MCF on FIBTEM 
represents qualitative assessment of fibrinogen levels 
(normal value; MCF on FIBTEM 9-25 mm).13)
　Results are expressed as median and observed 
range or mean ± SD. The general linear model was 
used to test changes between variables. A two-tailed 
 p value less than 0.05 was taken as a significant 
diference. Data analysis was performed using SPSS 
version 19.0.
　We received approval by the local ethics committee 
and written informed consent from each participant.
Results
　Twelve patients were enroled in this study. One did 
not transfuse autologous blood because of little 
bleeding, therefore he was excluded, leaving eleven 
patients for analysis in this study. Tables 1 and 2 
shows patients’ demographic and perioperative 
characteristics: the median age and body mass index 
(BMI) were 67.0 years and 23.3 kg m-2, respectively. 
The average blood loss was 1635 g. After induction, 
CT, CFT and MCF on EXTEM were 57.1 seconds, 
90.8 seconds and 61.2 mm, respectively, MCF in 
FIBTEM was 10.7 mm. In EXTEM, CT was slightly 
but significantly diferent between baseline and prior 
to transfusion (Figure 4). However, values were not 
significantly diferent among the other points. CFT 
was significantly prolonged and MCF was signifi-
cantly reduced prior to transfusion compared with 
baseline (Figure 5, 6). However, these impairments 
were not below the normal levels. Although these 
parameters were not significantly diferent at the end 
of surgery compared with prior to transfusion of 
Figure 2. ROTEM parameters. Clotting time (CT) is 
defined time from start of measurement until initiation 
of clotting. Clot firmness time (CFT) is defined time 
from initiation of clotting until a clot firmness of 20 mm. 
Maximum clot firmness (MCF) is the maximum 
amplitude. (Daniel B, Klaus G, Kenichi A. T: 
Pathophysiology and treatment of coagulopathy in 
massive hemorrhage and hemodilution. Anesthesiology, 
2010; 113: 1205-19)
Table 1. Patients’ demographic characteristics
Table 2. Patients’ perioperative characteristics
Figure 3. Representative profiles of EXTEM and 
FIBTEM measured at Yamagata University Hospital.
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autologous whole blood, CFT and MCF were 
significantly improved by the next morning. In 
FIBTEM, there were no significant diferences among 
samples obtained baseline, prior to transfusion of 
autologous whole blood and at the end of surgery. In 
contrast, MCF was significantly improved the 
morning after surgery compared with the end of the 
surgery (Figure 7). None of the patients needed 
transfusion of homologous blood products.
Discussions
　In this study, we showed that ROTEM parameters 
in patients undergoing radical prostatectomy were 
impaired by bleeding during the procedure. Transfu-
sion of autologous whole blood did not improve these 
parameters by bleeding during the intraoperative 
period. These parameters, except CT on EXTEM, 
improved the next morning after surgery. 
　When bleeding occurred during surgery, the initial 
treatment is usualy volume replacement with 
Figure 4. CT on EXTEM (* p<.05). The black line 
represents mean. The dotted lines represent the upper 
and lower normal limit.
Figure 5. CFT on EXTEM (*p<.05). The black line 
represents mean. The dotted lines represent the upper 
and lower normal limit.
Figure 6. MCT on EXTEM (**p<.01). The black line 
represents mean. The dotted lines represent the upper 
and lower normal limit.
Figure 7. MCF on FIBTEM (**p<.01). The black line 
represents mean. The dotted line represents the lower 
normal limit. 
Autologous transfusion assessed by ROTEM
－ 112 －
crystaloids or coloids to maintain systemic circula-
tion. In addition, alogeneic red cel concentrates are 
often transfusing to increase hemoglobin. However, 
these treatments consequently contribute to hemodi-
lution, which can lead to coagulopathy.12) Hippala et 
al. showed that the critical level of hemostatic factors 
(platelets, fibrinogen, prothrombin, coagulation 
factors) was observed after more than 150% blood loss 
of calculated blood volume, and that fibrinogen was 
the first factor that reaches low level.14) In a porcine 
model, approximately 65% of estimated blood loss 
volume and replacement with the same amount of 
gelatin solution made both of fibrinogen concentra-
tions and platelet count reduce, but only fibrinogen 
concentration reached critical level.15) These results 
represent that fibrinogen concentrations are the key 
factor for dilutional coagulopathy.
　Although conventional coagulation tests are 
common screening tests for coagulation dysfunction, 
they are not always useful for perioperative 
coagulopathy. They require a long turn-around time 
because the sample was transferred to the laboratory 
and centrifuged to separate plasma from whole blood. 
Furthermore, both tests do not provide any 
information on in vivo interaction of platelets with 
coagulation factors due to using only plasma.16) In this 
regard, ROTEM遺 can synergisticaly assess diferen-
tial parts of hemostasis such as the initiation of clot 
formation, the propagation, the stifness of clot, and 
the fibrinolysis because the whole blood sample from 
patient is investigated. It is beneficial for earlier 
recognition of a coagulopathy, because it can be 
performed at the bedside by using whole blood 
sample. Further, these results were visualy displayed 
the graphic date in real-time and represented various 
parts of hemostasis. Thereby early checkup and 
appropriate treatment are enabled during surgery. 
The ROTEM parameters and the definition were 
express in Figure 1. CT is the onset of clotting and 
means the initiation of coagulation. CFT is the initial 
rate of fibrin polymerization and means the 
propagation of coagulation (the interaction between 
fibrin and platelets). Alpha-angle is same as CFT. The 
maximum amplitude of waveform represents MCF, 
which means the clot strength.12) The EXTEM assay is 
performed by addition of tissue factor, and represents 
coagulation through the contact of extrinsic pathway. 
The FIBTEM assay is performed by addition of tissue 
factor and cytochalasin D, that is a platelet 
antagonist, and represents the efect of fibrin(ogen) 
on coagulation.2) Ogawa et al. have investigated the 
correlations between ROTEM parameters and 
conventional coagulation tests. There were significant 
correlations between PT and CT on EXTEM (r=0.55; 
p<0.001) and between PT and CFT on EXTEM 
(r=0.53; p<0.001). MCF on EXTEM correlated with 
both fibrinogen levels and platelet counts (r=0.69 and 
r=0.69, respectively; p<0.001). Excelent correlation 
was observed between MCF on FIBTEM and 
fibrinogen levels (r=0.85; p<0.001).17)
　In our study, the average blood loss was 1635 g, 
which seemed to be not great amount of blood loss, in 
fact, our results were normal level. Especialy, MCF 
on FIBTEM which represents fibrinogen concentra-
tions was 9.5mm prior to transfusion. There is a 
correlation between fibrinogen concentrations and 
MCF in FIBTEM, and the critical level of fibrinogen 
concentrations is generaly 2.0 g L-1, and that of MCF 
on FIBTEM is 8 mm.18) MCF on FIBTEM was 9.5 mm 
in our study, which represents the dilutional 
coagulopathy caused by bleeding in our procedure did 
not reach the critical level.
　A radical prostatectomy is one of operations that 
may result in massive hemorrhage. The bleeding 
more than the circulation blood volume occurred few 
frequently in al operation, and 2.8% were 
prostatectomy.19) Therefore, patients undergoing this 
procedure often prepared PABD as an aim of 
increasing RBC to maintain circulating oxygen-
carrying capacity. The potential benefits of PABD are 
not only the increment of RBC but also including the 
components of coagulation system. As mentioned 
above, Minatoguchi et al. have investigated coagula-
tion factors in whole blood stored at 4°C for five 
weeks.8) In this study, fibrinogen and factor Ⅶ were 
maintained above the critical level through the stored 
period although factor Ⅴ, Ⅷ, and von Wilebrand 
factor significantly decreased. On the other hand, 
factor Ⅹ Ⅲ slightly but significantly increased after 
the storage. In our study, the preservation period of 
blood was the range from one to four weeks. Although 
the preserved whole blood included fibrinogen in 
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theory, MCF on FIBTEM have not changed after 
transfusion. In conclusion, our study suggests the 
transfusion of the preserved autologous whole blood 
during surgery has a smal efect on coagulation 
activity in vivo. 
　When compared with parameters intraoperative 
period, al parameters after surgery improved. The 
improvement in the postoperative period may 
indicate homeostatic reactions after surgery. 
ROTEM遺 can capture the reaction correctly.
　Our study has some limitations. First, sample size 
was smal. Radical prostatectomy has recently been 
reduced because robotic-assisted laparoscopic radical 
prostatectomy (RALP) was brought in our hospital 
from August September 2012, after that RALP 
rapidly became mainstream. Because RALP hardly 
bled and did not prepare autologous transfusion, 
patients undergoing this procedure excluded from 
this study. Second, we did not have a protocol about 
the timing of transfusion. Third, hydroxyethyl starch 
has been found to afect ROTEM parameters.20) 
However, it was not influenced to the coagulopathy 
because the amount of it was equal to 1000ml or less. 
Finaly, platelet count was not investigated in our 
study. The platelet activity plays the important role in 
hemostasis. Interestingly, platelet count reached the 
critical level (which was 50×103/mm3) at 230% blood 
loss of calculated blood volume. In our study, we 
supposed the platelet count was maintained during 
surgery because MCF on EXTEM was not below 
normal level. In addition, there were not platelets in 
preserved whole blood at al because of low 
temperature preservation and anaerobic metabolism. 
Therefore, we did not investigate the efect of platelet 
activity in this study. 
Conclusion
　In conclusion, ROTEM parameters in patients 
undergoing radical prostatectomy were impaired by 
bleeding during the procedure. Transfusion of 
autologous whole blood did not alter these parameters 
during the intraoperative period. 
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